Xspray Pharma Signs First Licensing Deal, Eyes Dasynoc Launch

Xspray Pharma signed a deal with Handa Therapeutics that will give it up to double-digit royalties on Handa's net profits, marking the company's first out-licensing arrangement from its patent portfolio

STEER Unveils Breakthrough in Continuous Granulation Technology

STEER World, a global leader in advanced materials platform technology, has successfully demonstrated a 200 kg/hour continuous run of Metformin granules using its patented INTEGRAAL Continuous Granulation System

SCHOTT Launches Local Manufacturing of Syringe & Cartridge Glass in India

SCHOTT, the world leader in specialty glass production, has expanded its manufacturing plant in Jambusar, Gujarat, introducing Syringe and cartridge glass tubing made in India. This transforms SCHOTT into the biggest provider of syringe and cartridge

Specialty Pharmaceuticals Market: Global Trends and Forecast 2025

The global Specialty Pharmaceuticals Market is at the vanguard of healthcare innovation, stirred by cutting-edge treatments, quick development, and evolving industry trends. The global market size increased by USD 280.7 billion in 2024 and is expecte

US Expansion and New Launches Boost Quarterly Performance

The US market expansion through the introduction of new products in the gastrointestinal, pain management, and digestive health division’s propelled the company's reported revenue of Rs. 620 crore, up 5% year over year

Indoco Remedies Gets USFDA Nod for Rivaroxaban Tablets in US Market

Indoco Remedies Ltd. has obtained final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application

Eli Lilly Launches Mounjaro KwikPen in India for Diabetes Care

US pharmaceutical giant Eli Lilly stepped up competition with rival Danish drugmaker Novo Nordisk on Wednesday by introducing its popular diabetes medication Mounjaro in the Indian market. KwikPen is a single patient use prefilled pen intended for on

Zydus Lifesciences to Launch Semaglutide Variants for Global Markets

Zydus Lifesciences, a leading Indian pharmaceutical, is preparing to launch semaglutide variants, the active ingredient in antidiabetic and weight-loss drugs, as the patent nears expiration in 2026. The firm is expected to invest over ?100...

Zydus Q1 Revenue Rises 6% on Strong India Formulations and Global Growth

Zydus Lifesciences reported its consolidated revenue of Rs 65,737 million for Q1 FY26, highlighting a 6 percent YoY increase, while net profit rose 3 percent to Rs 14,668 million. The company has a strong foundation and plays

Asian Institute of Nephrology & Urology (AINU) inaugurates flagship hospital in Banjara Hills, Hyderabad

Asian Institute of Nephrology and Urology (AINU), India’s largest single-speciality chain focused on Uro-Nephro care, marks a new milestone with the expansion of its flagship hospital in Banjara Hills, Hyderabad. The flagship hospital has a combined

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.